Drinking beet juice associated with reduced restenosis after PCI

Published Date: 02 Mar 2023

Dietary nitrate in the form of beet juice reduces restenosis after percutaneous intervention in a randomized trial.

Read Full News

Latest News

CKM Syndrome Tied to Major Blinding Eye Diseases

Cardiovascular-kidney-metabolic syndrome is associated with an increased risk of developing major blinding eye diseases in a large UK cohort, with stage 3 showing the highest rates.

Is DTG/3TC Comparable to Triple Therapy in High Viral Load?

Dolutegravir/lamivudine shows comparable virologic suppression to bictegravir/emtricitabine/tenofovir alafenamide in HIV with very high viral loads, with no significant difference between the regimens.

Usual Tests May Miss Risks in Mild Pulmonary Hypertension

In patients with mild pulmonary hypertension, measures of pulmonary artery stiffness and right-ventricular function may predict survival better than traditional measures do.

Late Bleeding Events After PCI Tied to Higher Death Risk

After PCI, both ischaemic and bleeding complications are tied to a higher risk for death, but bleeding events occurring months after discharge carry a higher risk for death than late ischaemic events.

1-Year Tirzepatide, Ixekizumab Combo Trial Results Reported

Results from phase 3b trials show a greater benefit at 52 weeks for patients with psoriasis or psoriatic arthritis treated with ixekizumab plus tirzepatide vs ixekizumab alone.

Certain Social Factors Tied to Metabolic Liver Disease

Food insecurity and neighborhood deprivation were each independently associated with higher incidence of MASLD, with the highest incidence among adults experiencing both.

Todays Updates

Can 80 Gy Radiation Boost Survival in Prostate Cancer?

A modest increase in radiation dose improves progression-free survival over 10 years among men with high-risk prostate cancer — but the overall survival benefits found in a French trial are uncertain.

Todays Updates

Can 80 Gy Radiation Boost Survival in Prostate Cancer?

A modest increase in radiation dose improves progression-free survival over 10 years among men with high-risk prostate cancer — but the overall survival benefits found in a French trial are uncertain.

Latest News

Cardiovascular-kidney-metabolic syndrome is associated with an increased risk of developing major blinding eye diseases in a large UK cohort, with stage 3 showing the highest rates.

Dolutegravir/lamivudine shows comparable virologic suppression to bictegravir/emtricitabine/tenofovir alafenamide in HIV with very high viral loads, with no significant difference between the regimens.

In patients with mild pulmonary hypertension, measures of pulmonary artery stiffness and right-ventricular function may predict survival better than traditional measures do.

After PCI, both ischaemic and bleeding complications are tied to a higher risk for death, but bleeding events occurring months after discharge carry a higher risk for death than late ischaemic events.

Results from phase 3b trials show a greater benefit at 52 weeks for patients with psoriasis or psoriatic arthritis treated with ixekizumab plus tirzepatide vs ixekizumab alone.

Food insecurity and neighborhood deprivation were each independently associated with higher incidence of MASLD, with the highest incidence among adults experiencing both.

News All Time

Edoxaban Falls Short After Intracranial Hemorrhage in AF

Edoxaban reduced ischemic stroke after intracranial hemorrhage in patients with AF, but excess hemorrhagic stroke and major bleeding offset the benefit.

Tailored Approach Shortens Endocarditis Therapy

Tailored antibiotic therapy for infective endocarditis was associated with a significant reduction in treatment duration, according to an open-label multicenter trial.

Atorvastatin Cuts Major CV Events by 30% in Older Adults in STAREE

Statin use for primary cardiovascular prevention in adults aged 70 years or older is supported by data from STAREE, although treatment did not prolong disability-free survival.

Milvexian Fails to Reduce CV Events After ACS

Patients in the phase 3 LIBREXIA ACS trial showed no reduction in cardiovascular events after acute coronary syndrome.

Phase 3 Eplontersen Trial Results Disappoint

Despite a major reduction in transthyretin amyloid deposits, eplontersen, a drug that reduces TTR production, did not reduce events associated with TTR amyloidosis in a phase 3 trial.

Heart Failure Drug May Not Improve Exercise Fitness in nHCM

A heart failure drug combination may not improve exercise capacity in patients with nonobstructive hypertrophic cardiomyopathy but is associated with favorable cardiac structural remodeling.

DOACs Benefit AF Patients With Intermediate Stroke Risk

Anticoagulation reduced adverse clinical events in patients with atrial fibrillation at intermediate stroke risk, without an apparent increase in major bleeding.

Mounjaro FDA-Approved to Reduce Cardiovascular Risk in T2D

Lilly's Mounjaro (tirzepatide) is now approved to reduce cardiovascular risk in adults with type 2 diabetes.

Weight Down, Steps Down: The GLP-1 Catch

Studies suggest that strong recommendations for exercise with GLP-1s are commonly not heeded; possible reasons vary.

Ginseng, the ‘Miracle Root’: How Strong Is the Evidence?

Evidence varies across ginseng uses, with some potential benefits but limited support for treating fatigue, cognitive decline, infections, diabetes, or cardiovascular disease.

Inpatient Weight Loss May Cut HF Rehospitalization Risk

Losing weight during hospitalization for heart failure in patients treated with intravenous loop diuretics is associated with a reduced 30-day risk for rehospitalization.

Common Lipid-Lowering Drug May Slow Diabetic Eye Damage

A common lipid-lowering drug is tied to markedly lower odds of vision-threatening retinopathy, cataracts, and macular edema in patients with mild or moderate nonproliferative diabetic retinopathy.

What Is Fibermaxxing and Is More Fiber Always Better?

Higher-fiber intake is linked to important health benefits; however, benefits appear to plateau at moderate intake, whereas excessive amounts can cause gastrointestinal symptoms.

Diabetes Linked to Higher Risk for Sudden Cardiac Death

Diabetes may independently raise the risk for sudden cardiac death, regardless of obstructive coronary artery disease status.

Sleep Apnoea Tied to Heart Rhythm Risk in Dialysis Patients

Patients undergoing peritoneal dialysis who have sleep apnoea — particularly those older than 60 years — face an increased risk for new-onset atrial fibrillation, a Finnish study finds.

Overheard in Medicine: Who Owns the Incidental Finding?

Overhead in Medicine is a Medscape digest that surfaces a few of the week’s top posts from major medical subreddits.

Recommended News For You

Simpler Screening Criteria Could Catch More Lung Cancers

Multicomponent Test Tops PSA for Clinically Significant Prostate Cancers

Newly identified T-cell subtype may explain treatment-resistant childhood leukemia

Could semaglutide be used to treat addiction in addition to obesity?

Adaptive SABR-Used Hypofractionated Chemoradiation Showed Good Results in NSCLC.

No Benefit for PD-1 Inhibitors in Certain Gastroesophageal Cancers, FDA Panel Says

AI can identify women at risk of breast cancer years in advance: Study

Recommended Articles For You

Colorectal Cancer Incidence Trends: A Growing Concern in 2024 and 2025 

Unlocking the Secrets of Improved Ovarian Cancer Survival Rates 

Hematopoietic Microenvironment Rejuvenation Through Cellular Architecture Remodeling 

Metabolic Heterogeneity Driving Tumor Progression 

Whats more on Hidoc Dr.

Medical Updates
KOL Videos
Surveys
Events

Daily news to keep you up to date

Gain valuable insights with our in-depth KOL Video discussions

Participate and win cash vouchers

Get updates on the latest events happening around the world
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

The Clues Hidden in Failed Prostate Cancer Trials

2.

Updates from the 2022 WHO classification of kidney epithelial tumors

3.

Immunotherapy and targeted radiation shrink liver tumors, enabling surgery

4.

We Don't Always Know What's 'Best' for Our Patients

5.

Conditional EU Nod for Weekly Pill in Pediatric Glioma

1.

AI on the Front Lines: Revolutionizing Breast Cancer Detection with Artificial Intelligence

2.

Gynecologic Oncology: Advances, Education, and Clinical Excellence

3.

Integrating Immunotherapy and Staging Guidelines in Lung Cancer Treatment

4.

Contemporary Frameworks in Oncology Across Clinical Settings

5.

Unlocking the Immune Arsenal: A Revolution in Cancer Treatment

1.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

2.

International Cancer Conference

3.

Asian Symposium on Advancement in Hematology and Oncology (ASAHO)

4.

Asian Symposium on Advancement in Hematology and Oncology

5.

Asian Symposium on Advancement in Hematology and Oncology

1.

Pazopanib: A Game-Changer in Managing Advanced Renal Cell Carcinoma - Part II

2.

Oropharyngeal Cancer in Relation to HPV Status

3.

Navigating the Complexities of Ph Negative ALL - Part XV

4.

Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part V

5.

Efficient Management of First line ALK-rearranged NSCLC - Part II

Fastest Growing Medical Platform for Doctors

Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801

Phone :
+1-415-463-3094

Email :
anishagadia@hidoc.co

Quick Links

Drug DatabaseDrug InteractionDiseases Database
KOL VideosKnowledge HubQuizzes
Medical UpdatesEventsAbout Us

© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
Home
Profile
Login
bot